Which Israeli company is helping soccer players exercise their ‘mind muscles’ and why are the Chinese invading Ashdod?

CTech Daily Roundup: Israeli unicorn Sisense adopting new approach towards work post-Covid-19 shakeup

CTech 20:4611.10.20
Israeli unicorn Sisense adopting new approach towards work post-Covid-19 shakeup. The startup, which is considering an IPO in the coming year, has come up with an innovative vision for work that might not appeal to all employees. Read more

 

“Customers expect on-demand services and mobility companies need to keep up.” Speaking with CTech after Via’s acquisition of Fleetonomy, the two companies describe how they came together based on their shared understanding of coping with ‘the new normal’. Read more 

Cristiano Ronaldo. Photo: Reuters Cristiano Ronaldo. Photo: Reuters

HR Post Covid | Covid-19 changed the recruiting game, says Fundbox’s VP of People. Covid-19 disrupted not just how employees communicate with each other, but how companies communicate with potential new hires. Jenia Medvedev explains how in the latest Post-Covid HR series.

Read more

 

Israel’s Enroute selected to take part in Intelak’s Dubai-based incubator. Enroute provides users with a personalized commerce platform for ride hailing and mass transit applications which allows them to travel for free while shopping online. Read more

 

Interview | Neura offers governments the behavioral data they need to live with Covid-19. The Israeli company realized that human behavior is the key to understanding the spread of coronavirus and encouraging a change is needed to cope with the pandemic. Read more  

 

i-BrainTech helps soccer players exercise their ‘mind muscles’. Blending neuroscience and analytics, i-BrainTech taps into the minds of sports players to help bring their game to excellence. Read more

 

Interview | Ashdod is primed for the Chinese invasion. Deputy mayor Sharon Mark talks about the port city’s efforts to take its businesses virtual and its path to becoming Israel’s e-commerce capital. Read more

 

Opinion | Nobel Prize for CRISPR inventors re-sparks the debate on science’s ethical boundaries. The purported facility of the DNA-editing process raises numerous questions and concerns over the control and regulation of the technology. Read more